These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8699854)
1. Pentoxifylline for the treatment of HIV infection and its complications. Dezube BJ; Lederman MM J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S139-42. PubMed ID: 8699854 [TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumour necrosis factor synthesis or nuclear factor-kappa B activation. Navarro J; Punzón MC; Pizarro A; Fernández-Cruz E; Fresno M; Muñoz-Fernández MA AIDS; 1996 May; 10(5):469-75. PubMed ID: 8724037 [TBL] [Abstract][Full Text] [Related]
4. High-dose pentoxifylline in patients with AIDS: inhibition of tumor necrosis factor production. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. Dezube BJ; Lederman MM; Spritzler JG; Chapman B; Korvick JA; Flexner C; Dando S; Mattiacci MR; Ahlers CM; Zhang L J Infect Dis; 1995 Jun; 171(6):1628-32. PubMed ID: 7769305 [TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL). Sampaio EP; Moraes MO; Nery JA; Santos AR; Matos HC; Sarno EN Clin Exp Immunol; 1998 Feb; 111(2):300-8. PubMed ID: 9486396 [TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline and other protein kinase C inhibitors down-regulate HIV-LTR NF-kappa B induced gene expression. Biswas DK; Ahlers CM; Dezube BJ; Pardee AB Mol Med; 1994 Nov; 1(1):31-43. PubMed ID: 8790599 [TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia. Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898 [TBL] [Abstract][Full Text] [Related]
8. Cooperative inhibition of NF-kappa B and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat. Biswas DK; Ahlers CM; Dezube BJ; Pardee AB Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11044-8. PubMed ID: 8248210 [TBL] [Abstract][Full Text] [Related]
9. Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication. Angel JB; Saget BM; Walsh SP; Greten TF; Dinarello CA; Skolnik PR; Endres S AIDS; 1995 Oct; 9(10):1137-44. PubMed ID: 8519449 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 replication by combination of a novel inhibitor of TNF-alpha with AZT. Biswas DK; Mhashilkar AM; Ewaniuk DS; Pezza JA; Oh LM; Kannangara GS; Tius MA; Pardee AB J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):426-34. PubMed ID: 9715838 [TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells. Fazely F; Dezube BJ; Allen-Ryan J; Pardee AB; Ruprecht RM Blood; 1991 Apr; 77(8):1653-6. PubMed ID: 1707692 [TBL] [Abstract][Full Text] [Related]
12. LPS-stimulated PMN activation and proinflammatory mediator synthesis is downregulated by phosphodiesterase inhibition: role of pentoxifylline. Coimbra R; Loomis W; Melbostad H; Tobar M; Porcides RD; Hoyt DB J Trauma; 2004 Dec; 57(6):1157-63. PubMed ID: 15625444 [TBL] [Abstract][Full Text] [Related]
13. Nonspecific phosphodiesterase inhibition attenuates liver injury in acute endotoxemia. Coimbra R; Porcides RD; Melbostad H; Loomis W; Tobar M; Hoyt DB; Wolf P Surg Infect (Larchmt); 2005; 6(1):73-85. PubMed ID: 15865553 [TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial. Wallis RS; Nsubuga P; Whalen C; Mugerwa RD; Okwera A; Oette D; Jackson JB; Johnson JL; Ellner JJ J Infect Dis; 1996 Oct; 174(4):727-33. PubMed ID: 8843209 [TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline promotes replication of human cytomegalovirus in vivo and in vitro. Staak K; Prosch S; Stein J; Priemer C; Ewert R; Docke WD; Kruger DH; Volk HD; Reinke P Blood; 1997 May; 89(10):3682-90. PubMed ID: 9160673 [TBL] [Abstract][Full Text] [Related]
16. Effects of pentoxifylline on TNF-alpha production by peripheral blood mononuclear cells in patients with nonalcoholic steatohepatitis. Duman DG; Ozdemir F; Birben E; Keskin O; Ekşioğlu-Demiralp E; Celikel C; Kalayci O; Kalayci C Dig Dis Sci; 2007 Oct; 52(10):2520-4. PubMed ID: 17436095 [TBL] [Abstract][Full Text] [Related]
17. The maximal tolerable intravenous dosage of pentoxifylline in AIDS patients does not inhibit lipopolysaccharide-stimulated tumor necrosis factor alpha production. Heijligenberg R; Romijn JA; Ackermans M; Endert E; Timmer JG; Sauerwein HP AIDS Res Hum Retroviruses; 1998 Mar; 14(4):299-303. PubMed ID: 9519890 [TBL] [Abstract][Full Text] [Related]
18. Phase I/II study of pentoxifylline with zidovudine on HIV-1 growth in AIDS patients. Luke DR; McCreedy BJ; Sarnoski TP; Bookout JB; Johnston AM; Lell JE; Wiggan EB; Bell N; Limjuco RA; Guthrie KI Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):343-50. PubMed ID: 8370633 [TBL] [Abstract][Full Text] [Related]
19. Insights into the regulation of TNF-alpha production in human mononuclear cells: the effects of non-specific phosphodiesterase inhibition. Deree J; Martins JO; Melbostad H; Loomis WH; Coimbra R Clinics (Sao Paulo); 2008 Jun; 63(3):321-8. PubMed ID: 18568240 [TBL] [Abstract][Full Text] [Related]
20. Overcoming TNF-alpha and drug resistance of human renal cell carcinoma cells by treatment with pentoxifylline in combination with TNF-alpha or drugs: the role of TNF-alpha mRNA downregulation in tumor cell sensitization. Mizutani Y; Bonavida B; Nio Y; Yoshida O J Urol; 1994 Jun; 151(6):1697-702. PubMed ID: 8189599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]